- Home
- MCBS vs MRVI Comparison
MCBS vs MRVI Comparison
Compare MCBS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCBS
- MRVI
- Stock Information
- Founded
- MCBS 2006
- MRVI 2020
- Country
- MCBS United States
- MRVI United States
- Employees
- MCBS N/A
- MRVI N/A
- Industry
- MCBS Major Banks
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- MCBS Finance
- MRVI Health Care
- Exchange
- MCBS Nasdaq
- MRVI Nasdaq
- Market Cap
- MCBS 753.4M
- MRVI 809.2M
- IPO Year
- MCBS 2019
- MRVI 2020
- Fundamental
- Price
- MCBS $31.74
- MRVI $4.77
- Analyst Decision
- MCBS Hold
- MRVI Buy
- Analyst Count
- MCBS 1
- MRVI 10
- Target Price
- MCBS $36.00
- MRVI $10.28
- AVG Volume (30 Days)
- MCBS 45.1K
- MRVI 1.8M
- Earning Date
- MCBS 01-28-2025
- MRVI 02-25-2025
- Dividend Yield
- MCBS 2.90%
- MRVI N/A
- EPS Growth
- MCBS 17.79
- MRVI N/A
- EPS
- MCBS 2.33
- MRVI N/A
- Revenue
- MCBS $135,566,000.00
- MRVI $276,920,000.00
- Revenue This Year
- MCBS N/A
- MRVI N/A
- Revenue Next Year
- MCBS $3.39
- MRVI $2.25
- P/E Ratio
- MCBS $13.62
- MRVI N/A
- Revenue Growth
- MCBS 11.66
- MRVI N/A
- 52 Week Low
- MCBS $21.89
- MRVI $4.28
- 52 Week High
- MCBS $36.15
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- MCBS 47.59
- MRVI 39.85
- Support Level
- MCBS $31.11
- MRVI $4.38
- Resistance Level
- MCBS $32.35
- MRVI $6.21
- Average True Range (ATR)
- MCBS 1.40
- MRVI 0.39
- MACD
- MCBS 0.05
- MRVI -0.09
- Stochastic Oscillator
- MCBS 44.58
- MRVI 21.31
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.